21 May 2013
Keywords: elan, prialt, meets, goals, ph, iii, trial
Article | 19 January 2004
Dublin, Ireland-headquartered Elan has revealed that it is to submit an amendment to its New Drug Application for its pain ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 January 2004
5 July 2004
20 May 2013
© 2013 thepharmaletter.com